Aloxi
- Product NDC
- 69639-103
- 11-digit product format
- 696390103
- Labeler code
- 69639
- Product ID
- 69639-103_e440c700-5ea8-6ada-e053-2a95a90a6769
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- palonosetron hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Application
- NDA021372
- Marketing category
- NDA
- Marketing start
- 2018-11-01
- Marketing end
- 2022-11-01
- Substance
- PALONOSETRON HYDROCHLORIDE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69639-103-01 | 69639010301 | 1 VIAL in 1 CARTON (69639-103-01) > 5 mL in 1 VIAL | 1 vial | 2018-11-01 | 0000-00-00 | No | No | Current |
| 69639-103-05 | 69639010305 | 1 VIAL in 1 CARTON (69639-103-05) > 1.5 mL in 1 VIAL | 1 vial | 2018-11-01 | 0000-00-00 | No | No | Current |